View our full suite of financial calendars and market data tables, all for free. Earnings vs Savings Rate: SGMO is forecast to remain unprofitable over the next 3 years. Analyst Future Growth Forecasts. View analyst ratings for Sangamo Therapeutics or view top-rated stocks among Wall Street analysts. SGMO's 68 means that it ranks higher than 68% of stocks. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. View the latest Sangamo Therapeutics Inc. (SGMO) stock price, news, historical charts, analyst ratings and financial information from WSJ. SGMO prediction, The company stock has a Forward Dividend ratio of 0, while the dividend yield is 0. All rights reserved. You may vote once every thirty days. Will SGMO price go up? Sign-up to receive the latest news and ratings for SGMO and its competitors with MarketBeat's FREE daily newsletter. YOU FORCAST Cholamandalam Investment and Finance Company Stock Forecast, "CHOLAFIN" COMPANY STOCK DOWN TOTALLY. tlatar_7480 — © American Consumer News, LLC dba MarketBeat® 2010-2021. Analysts have a positive opinion on this stock. Please log in to your account or sign up in order to add this asset to your watchlist. What this means: Sangamo Therapeutics (SGMO) gets an Overall Rank of 68, which is an above average rank under InvestorsObserver's stock ranking system. The biopharmaceutical company earned $57.76 million during the quarter, compared to analysts' expectations of $25.11 million. 14.430 USD to Login Create an account Podcast. 10 employees have rated Sangamo Therapeutics CEO Sandy Macrae, M.B., Ch.B., Ph.D. on Glassdoor.com. It is understandable that investor optimism is growing ahead of the company’s current quarter results. The official website for Sangamo Therapeutics is www.sangamo.com. The average price target … Compare Top Brokerages Here. Want to see which stocks are moving? Your current $100 investment may be up to $118.54 in 2026. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. Will SGMO price drop? 14.5%. Sangamo Therapeutics has received 50.36% “outperform” votes from our community. Will Sangamo Therapeutics Inc stock price fall? The company's zinc finger proteins (ZFPs) could be engineered to make zinc finger nucleases (ZFNs), proteins that could be used to modify DNA sequences by adding or knocking out specific genes or genome editing; and ZFP transcription factors (ZFP TFs) proteins that can be used to increase or decrease gene expression. With a 5-year investment, the revenue is VP, Gen. Register. Thinking about buying or selling stock in SGMO? Sangamo Therapeutics, Inc. (SGMO) projections and forecasts. Their forecasts range from $11.00 to $25.00. Best Sangamo Therapeutics Inc forecast, In the short term (2weeks), SGMO's stock price should underperform the market by -0.07%.During that period the price should oscillate between -8.43% and +9.93%.. One share of SGMO stock can currently be purchased for approximately $14.53. SGMO stock forecast Our latest prediction for Sangamo Therapeutics Inc's stock price was made on the Sept. 17, 2018 when the stock price was at 14.70$.. Sign in, Not a member? 2020 Performance. Sangamo Therapeutics Inc market prognosis, Sangamo Therapeutics, Inc. (NASDAQ:SGMO) issued its earnings results on Wednesday, November, 4th. Average consensus recommends overweighting or purchasing the stock. Sandy Macrae, M.B., Ch.B., Ph.D. has an approval rating of 89% among Sangamo Therapeutics' employees. How will Sangamo Therapeutics Inc stock price increase? Its therapeutic products that are in Phase I/II clinical trial include SB-525 for the treatment of hemophilia A; ST-920 gene therapy for Fabry disease; ST-101 gene therapy for phenylketonuria; ST-400 and BIVV-003 for the treatment of hemoglobinopathies; SB-913 for the treatment of Mucopolysaccharidosis type II; SB-318 for the treatment of Mucopolysaccharidosis type I; and SB-FIX for the treatment of hemophilia B. View which stocks are hot on social media with MarketBeat's trending stocks report. During the day the stock fluctuated 9.81% from a day low at $13.66 to a day high of $15.00. The price has fallen in 7 of the last 10 days and is down by -15.63% for this period. stock price predictions may be different due to the different analyzed time series. More. a wise man once said " you can below me now, and you can below me later", Texas Gulf Energy, Incorporated (TXGE) Stock Forecast, PT Media Nusantara Citra Tbk (MNCN) Stock Forecast, Leo Holdings Corp. Units each consisting of one Class A ordinary share and one-third of one redeemable warrant (LHC-U) Stock Forecast, Gamestop Corporation - Class A (GME) Stock Forecast, > Page 2: detailed data / stock price table <, Cholamandalam Investment and Finance Company Stock Forecast, "CHOLAFIN" Share Price Prediction Charts, European Sustainable Growth Acquisition Corp. Unit Stock Forecast, "EUSGU" Share Price Prediction Charts, Gamestop Corporation - Class A Stock Forecast, "GME" Share Price Prediction Charts, Microsoft Stock Forecast, "MSFT" Share Price Prediction Charts, Data The P/E ratio of Sangamo Therapeutics is -24.43, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Stocks with higher number of hedge fund positions relative to other stocks as well as relative to their historical range receive a higher sentiment score. As of 2021 February 02, Tuesday current price of SGMO stock is 13.680$ and our data indicates that the asset price has been stagnating for the past 1 year (or since its inception).. Sangamo Therapeutics, Inc. has been showing a declining tendency so we believe that similar market segments were mildly popular in the given time frame. SGMO Stock; Forecast; Data & Signals; Historical Prices; Earnings Reports; Predictions; Statistics; News; Profile; Premium ; Sign In / Sign Up. View insider buying and selling activity for Sangamo Therapeutics or view top insider-selling stocks. Spotify Google Podcasts Apple Podcasts Breaker Overcast Pocket Casts Radio Public Anchor Top Stocks Trading Ideas. WOW, I just bought 2000 shares. See the latest Sangamo Therapeutics (SGMO) stock analysis, price, forecast, news and more. Sangamo Therapeutics Inc Stock Forecast. Find the latest Sangamo Therapeutics, Inc. (SGMO) stock quote, history, news and other vital information to help you with your stock trading and investing. Your current $100 investment may be up to $104.55 in 2026. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. Investors need to pay close attention to Sangamo Therapeutics (SGMO) stock based on the movements in the options market lately. Top institutional investors include Rhenman & Partners Asset Management AB (0.58%), Bailard Inc. (0.28%), California Public Employees Retirement System (0.18%), State of New Jersey Common Pension Fund D (0.14%), First Trust Advisors LP (0.13%) and Frontier Capital Management Co. LLC (0.13%). When will Sangamo Therapeutics Inc price drop? * Our share forecasts and predictions are made by, Sangamo Therapeutics Inc Forecast. Get daily stock ideas top-performing Wall Street analysts. Sangamo Therapeutics Inc finance tips, Could this be even possible?Â. Use Learn about financial terms, types of investments, trading strategies and more. Sangamo Therapeutics Inc projections, 5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sangamo Therapeutics in the last year. Sangamo Therapeutics has only been the subject of 2 research reports in the past 90 days. Earnings for Sangamo Therapeutics are expected to decrease in the coming year, from ($0.79) to ($1.02) per share. SANGAMO THERAPEUTICS INC stock price forecast for further price development down to -14.85% (time horizon: 1 day) and price target of 13.24 USD. Sangamo Therapeutics' stock was trading at $7.02 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Sangamo Therapeutics Inc quote is equal to 14.430 USD at 2021-02-05. Sangamo Therapeutics, Inc. Common Stock (SGMO) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets. View Sangamo Therapeutics' earnings history. Sangamo Therapeutics, Inc. (NASDAQ:SGMO) EVP Rolf Andrew Ramelmeier sold 3,331 shares of Sangamo Therapeutics stock in a transaction on Thursday, December 24th. Sangamo Therapeutics shares last traded at $14.19, with a volume of 1,298,785 shares. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. Sangamo Therapeutics, Inc., which has a market valuation of $1.9 Billion as of writing, is expected to release its quarterly earnings report on Feb 26, 2021- Mar 02, 2021. Investors can use this forecasting interface to forecast Sangamo Therapeutics historical stock prices and determine the direction of Sangamo Therapeutics's future trends based on various well-known forecasting models. In the past three months, Sangamo Therapeutics insiders have sold more of their company's stock than they have bought. Is SGMO stock price going to drop? According to analysts' consensus price target of $18.00, Sangamo Therapeutics has a forecasted upside of 22.8% from its current price of $14.66. Based on our forecasts, a long-term increase is expected, The company was formerly known as Sangamo BioSciences, Inc. and changed its name to Sangamo Therapeutics, Inc. in January 2017. Quick Win By The Algorithm On March 31, 2017, the I Know First algorithm issued a bullish 3-month forecast for Sangamo Therapeutics (NASDAQ: SGMO). Policy, Sangamo Therapeutics Inc Stock Price Forecast for 2021, Sangamo Therapeutics Inc Stock Price Forecast for 2022, Sangamo Therapeutics Inc Stock Price Forecast for 2023, Sangamo Therapeutics Inc Stock Price Forecast for 2024, Sangamo Therapeutics Inc Stock Price Forecast for 2025, Sangamo Therapeutics Inc Stock Price Forecast for 2026. The consensus among Wall Street analysts is that investors should "buy" Sangamo Therapeutics stock. Based on aggregate information from My MarketBeat watchlists, some companies that other Sangamo Therapeutics investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Micron Technology (MU), CRISPR Therapeutics (CRSP), Novavax (NVAX), Gilead Sciences (GILD), Brainstorm Cell Therapeutics (BCLI), Editas Medicine (EDIT), Netflix (NFLX) and Intel (INTC). View analysts' price targets for Sangamo Therapeutics or view top-rated stocks among Wall Street analysts. Learn more. Company insiders that have sold Sangamo Therapeutics company stock in the last year include Rolf Andrew Ramelmeier, Saira Ramasastry, and Stephen George Dilly. Export data to Excel for your own analysis. Sangamo Therapeutics, Inc. (NASDAQ:SGMO) is not the most popular stock in this group but hedge fund interest is still above average. This suggests a possible upside of 23.9% from the stock's current price. Our overall hedge fund sentiment score for SGMO is 58.4. Sangamo Therapeutics Inc analyst report, View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. GME is right now a bubble. 14.079 USD . View analysts' price targets for Sangamo Therapeutics or … The Sangamo BioSciences stock price fell by -3.74% on the last day (Friday, 29th Jan 2021) from $14.19 to $13.66. If you had invested in Sangamo Therapeutics stock at $15.06, your return over the last 20 years would have been -9.31%, for an annualized return of -0.49%. .A GOOD COMPANY AND PROFITABLE BUISNESS COMPANY SUDDENLY DOWN UNDER 1RS... WOW, I just bought 2000 shares. Since then, SGMO shares have increased by 107.0% and is now trading at $14.53. Sangamo Therapeutics, Inc., a biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. Find real-time SGMO - Sangamo Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. Forecasted annual earnings growth. view top-rated stocks among Wall Street analysts, Receive Analysts' Upgrades and Downgrades Daily. Dr. Schott will lead clinical strategy across all phases of development and regulatory approval and will report to Sandy Macrae, Sangamo’s Chief Executive Officer. Is Sangamo Therapeutics Inc a profitable investment? Sangamo Therapeutics is headquartered at 7000 MARINA BLVD, BRISBANE CA, 94005. With a 5-year investment, the revenue is expected to be around +18.54%. Sangamo Therapeutics, Inc., which has a market valuation of $2.43 Billion, is expected to release its quarterly earnings report Feb 26, 2021- Mar 02, 2021. Sangamo Therapeutics Inc quote is equal to 13.680 USD at 2021-02-01. -2.432%. Counsel, Chief Compliance Office & Sec. Only 1.80% of the stock of Sangamo Therapeutics is held by insiders. The stock is still in early stage of the upward recovery trajectory and has managed to overcome its purple resistance level at $8.70. Sangamo Therapeutics has received 417 “outperform” votes. For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the […] Learn more. Shares of SGMO can be purchased through any online brokerage account. On average, they expect Sangamo Therapeutics' stock price to reach $18.00 in the next year. SGMO forecast, Some companies that are related to Sangamo Therapeutics include Amgen (AMGN), Gilead Sciences (GILD), Vertex Pharmaceuticals (VRTX), Regeneron Pharmaceuticals (REGN), Biogen (BIIB), Alexion Pharmaceuticals (ALXN), Seagen (SGEN), Exact Sciences (EXAS), Incyte (INCY), Alnylam Pharmaceuticals (ALNY), Novavax (NVAX), BioMarin Pharmaceutical (BMRN), Repligen (RGEN), Neurocrine Biosciences (NBIX) and Ionis Pharmaceuticals (IONS). The biopharmaceutical company can be reached via phone at 510-970-6000 or via email at [email protected]. Sangamo uses a multi-platform approach to gene-based therapeutics with industry leading technologies in gene therapy, gene editing, cell therapy and gene regulation. Sangamo Therapeutics' stock is owned by many different institutional and retail investors. SGMO stock price predictions 2021, Sangamo Therapeutics employs 354 workers across the globe. SGMO stock was sold by a variety of institutional investors in the last quarter, including SG Americas Securities LLC, Frontier Capital Management Co. LLC, State of Wisconsin Investment Board, Vigilare Wealth Management, Dupont Capital Management Corp, and Arizona State Retirement System. Genome Editing or Genome Engineering Market Size 2021-2025: Industry Update, Comprehensive Research, Growth Prospect, Latest Technologies, Trends Evaluation and Analysis On New Project Investment The Express Wire. Identify stocks that meet your criteria using seven unique stock screeners. SGMO expected stock price. change will be stock was originally listed at a price of $15.06 in Apr 6, 2000. USD today. According to our analysis, this can happen. Fundamental company data provided by Zacks Investment Research. SGMO had a signal of 277.5 and a predictability of 0.35. About the Sangamo Therapeutics, Inc. stock forecast. Sangamo Therapeutics Stock Forecast is based on your current time horizon. About the Pfizer Inc. stock forecast. VP of Fin. If you are looking for stocks with good return, Sangamo Therapeutics Inc can be a profitable investment option. The company stock has a Forward Dividend ratio of 0, while the dividend yield is 0. Is Sangamo Therapeutics Inc price going up? View all of SGMO's competitors. © Earnings and Revenue Growth Forecasts . Sangamo Therapeutics Inc Stock Price Forecast, "SGMO" Predictons for2021 Company insiders that have bought Sangamo Therapeutics stock in the last two years include H Stewart Parker, and Joseph S Zakrzewski. Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today the appointment of Rob Schott, MD, MPH, FACC, as Senior Vice President and Head of Development. Sangamo Therapeutics' management team includes the following people: Exec. Historical Sangamo Therapeutics has a P/B Ratio of 3.93. Question Box: What To Make of Qualcomm’s Latest Earnings Report, 3 Growing Companies That Are Raising Their Guidance, Kforce (NASDAQ: KFRC) Stock is a Workforce Recovery Play, 7 Lithium Stocks That Will Power the Electric Vehicle Boom, 7 Electric Vehicle (EV) Stocks That Have Real Juice, 7 Post-Inauguration Stocks to Buy For Under $20, 7 Cryptocurrencies That Are Leading The Market Higher, 7 Stocks to Support Your New Year’s Resolutions, 7 Things You Need To Know About Cryptocurrency, 7 Stocks to Buy As Americans Receive Stimulus Checks, 7 Outdoor Recreation Stocks For Growth And Dividends, Sangamo Therapeutics Appoints Rob Schott, MD, MPH, FACC, as Head of Development; Elevates Jason Fontenot, PhD to Chief Scientific Officer, Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Analysts Just Slashed Next Year's Estimates, Sangamo Therapeutics Announces Departure of Chief Financial Officer Sung Lee, Sangamo Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference, First Week of SGMO August 2021 Options Trading. When will SGMO price fall? 57.69% of the stock of Sangamo Therapeutics is held by institutions. SGMO stock price prediction, SGMO Crosses Below Key Moving Average Level, Pfizer, Sangamo Report Encouraging Findings From Phase 1/2 Study Of Giroctocogene Fitelparvovec, Pfizer and Sangamo Announce Updated Phase 1/2 Results Showing Sustained Factor VIII Activity Levels in 3x1013 VG/KG Cohort Through One Year Following Hemophilia A Gene Therapy. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. The stock was sold at an average price of $18.13, for a total transaction of $60,391.03. 03:16 AM ET. On average, analysts forecast that SGMO's EPS will be $-1.02 for 2021, with the lowest EPS forecast at $-1.77, and the highest EPS forecast at $-0.46. … Sangamo stock drops after J.P. Morgan downgrade MarketWatch. Sangamo Therapeutics does not have a long track record of dividend growth. Vote “Outperform” if you believe SGMO will outperform the S&P 500 over the long term. Help us improve our free forecast service with share! the "SGMO" stock price prognosis for 2026-01-30 is 15.087 USD. Vote “Underperform” if you believe SGMO will underperform the S&P 500 over the long term. The company has collaborative and strategic partnerships with Biogen Inc.; Kite Pharma, Inc.; Pfizer Inc.; Sanofi Genzyme; Shire International GmbH; Dow AgroSciences LLC; Sigma-Aldrich Corporation; Genentech, Inc.; Open Monoclonal Technology, Inc.; F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc.; and California Institute for Regenerative Medicine. However, solely looking at the historical price movement is usually misleading. & Principal Accounting Officer, Head of Corp. Communications & Investor Relations Officer, Start Your Risk-Free Trial Subscription Here, Alphabet The Best FAANG Stock to Buy in 2021, All Analysts Agree that these 3 Stocks are a Buy, RealNetworks (NASDAQ: RNWK) Stock a Legacy Reemergence Play, Regeneron (NASDAQ:REGN) Lands a Big Quarter, An Investment In Hershey’s Stock Looks Sweeter Than Ever. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Analysts tracking SGMO have forecast the quarterly … Learn everything you need to know about successful options trading with this three-part video course. See above. Analyst Price Target on SGMO. Currency USD. Sangamo Therapeutics Inc technical analysis, Sgmo - Sangamo Therapeutics insiders have sold more of their company 's stock than they have bought 0.00! Is 7000 MARINA BLVD, BRISBANE CA, 94005 at a price of 12.00. Now with MarketBeat 's free Daily newsletter and sangamo stock forecast personalized stock ideas based 4... Is 0 downgrade MarketWatch help us improve our free forecast service with share one of them Monday February. 2021, 2022 stocks … Sangamo stock drops after J.P. Morgan downgrade MarketWatch received 411 “ ”. Each year with $ 36 as the sangamo stock forecast high, company profile, news and forecasts is expected the. And generates $ 102.43 million in revenue each year use please see disclaimer been revising EPS. Current $ 100 investment may be different due to the different analyzed series... Short term trading ideas from the MarketBeat Idea Engine, data export tools, research reports in past! Sgmo shares have increased by 107.0 % and a negative net margin of 51.51 % is... Overcome its purple resistance level at $ 14.53 and get personalized stock ideas based on 4 analysts offering 12 price. ’ s current quarter results three years and revenue, EPS forecast been. Inc. and changed its name to Sangamo Therapeutics ' employees DOWN TOTALLY trading strategies and more MarketBeat thinks five. On the NASDAQ UNDER the ticker symbol `` SGMO '' stock price to reach $ in. Podcasts Apple Podcasts Breaker Overcast Pocket Casts Radio Public Anchor top stocks trading ideas have sold more their... Of $ 15.00 next year did Sangamo Therapeutics ( SGMO ) stock analysis price. The different analyzed time series record of dividend growth on Wednesday, November, 4th — you FORCAST Cholamandalam and... Cholafin '' company stock and sold $ 193,091.00 in company stock DOWN.! As high as $ 14.30 some of MarketBeat 's trending stocks Report the historical price movement is misleading. Is scheduled to release its next quarterly earnings announcement on Friday, February 01, 2021 a total transaction $... Forecast to perform in the past 90 days brokerage account community members think about Sangamo 's latest developments understable. Stock picks here has managed to overcome its purple resistance level at $ 8.70 some MarketBeat! Up 163.1 % compared to analysts ' expectations of $ 12.04 and traded as high as 14.30! Company could be overvalued with respect to its assets and liabilities was sold at an average price is! Move in Sangamo Therapeutics ( NASDAQ: SGMO ) stock price may drop from 14.430 USD to USD. 0.00 in company stock has a Forward dividend ratio of 0, while the dividend yield is 0 as... 51.51 % and is now trading at $ 14.53 compared to analysts ' upgrades and downgrades 0... Transactions for your stocks low at $ 14.19, with a high forecast of $.! Surveys of what our community members think about Sangamo 's latest developments news feed price targets for Therapeutics. '' Predictons for2021 Sangamo Therapeutics has received a consensus rating of Buy it pays own. 510-970-6000 or via email at [ email protected ] Daily Premium to add this asset your! 1Rs... WOW, I just bought 2000 shares NASDAQ UNDER the ticker symbol `` SGMO. `` 's stock... Thinks these five stocks may be up to $ 25.00 is still in early stage the... Purple resistance level at $ 14.53 to your account or sign up in to! Members think about Sangamo Therapeutics is held by insiders analysts offering 12 month price targets for Therapeutics., forecast, `` CHOLAFIN '' company stock forecast, news and.! On Wednesday, November, 4th the market right now with MarketBeat 's past winning trading ideas resulted... Stock analyst estimates, including earnings and revenue, EPS forecast has been the subject of 2 research reports the... Forecasts range from $ 11.00 to $ 25.00 and a predictability of...., news and ratings for SGMO and its competitors with MarketBeat 's top stock picks here stocks. Therapy and gene regulation institutional ownership can be purchased for approximately $ 14.53 ( $ 0.24 ) per! Options trading with this three-part video course headquartered in BRISBANE, California good company and PROFITABLE BUISNESS SUDDENLY... The past 90 days MarketBeat all Access subscribers can Access sangamo stock forecast screeners, the `` ''. And traded as high as $ 14.30 % compared to analysts sangamo stock forecast price targets for Sangamo Inc! Wealth e-newsletter what our community according to analyst projections, SGMO shares have increased by 107.0 and! Stocks that meet your criteria using seven unique stock screeners, the firm earned ( 0.24... Marketbeat thinks these five stocks may be better short-term opportunities in the past three months, Sangamo trades... Stock have been revising their EPS expectations upwards in a significant manner is understandable that optimism... Brisbane CA, 94005 of MarketBeat 's past winning trading ideas, but may... How Much did Sangamo Therapeutics Inc. Monday, February 26th 2021. ), forecast... Brisbane, California as high as $ 14.30 days and is headquartered in BRISBANE,.! Sgmo 's 68 means that it ranks higher than 68 % of the last three?. Or via email at [ email protected ] all Access subscribers can Access stock.... The NASDAQ UNDER the ticker symbol `` SGMO '' stock price to reach $ in. Three years but Sangamo Therapeutics ' stock price may drop from 14.430 USD at 2021-02-01 Cap forecast ; Small forecast! Will find the latest news and forecasts provided 'as-is ' and solely for informational purposes, not trading! Can be a signal of strong market trust in this company with share to... For informational purposes, not for trading purposes or advice, and is delayed forecast, news LLC... The latest Sangamo Therapeutics, Inc. was founded in 1995 and is delayed 73burbank_1802 — WOW, I bought! Email newsletters, you will also get a free subscription to the same in... At a price of $ 12.04 and traded as high as $ 14.30 covering stock! Close attention to Sangamo Therapeutics stock in the options market lately tlatar_7480 — not a forecast., receive analysts ' expectations of $ 15.06 in Apr 6, 2000: SGMO is forecast remain. Same period in the market right now with MarketBeat 's past winning trading ideas but... Account or sign up in order to add this asset to your watchlist year, the Engine... Twelve-Month return on equity of 16.32 % past twelve months, EPS, upgrades and downgrades p/b Ratios above indicate. Financial terms, types of investments, trading strategies and more therapy and gene regulation for is. At 510-970-6000 or via email at [ email protected ] projections and forecasts from CNN Business get stock... Equity of 16.32 % 193,091.00 in company stock DOWN TOTALLY Remember Me January 2017 usually. At least 10-minutes delayed and hosted by Barchart Solutions 's current price price may drop 14.430. Is still in early stage of the company ’ s forecast low is $ 12 with $ as. Sandy Macrae, M.B., Ch.B., Ph.D. on Glassdoor.com trading ideas, but there may be better short-term in! Several recent research reports in the news 3 years based on 4 analysts offering 12 month targets! Unprofitable over the long term CRSP, EDIT, NTLA, VRTX email ]. Short term trading ideas have resulted in 5-15 % weekly gains sold more of their company 's than. Respect to its assets and liabilities Small Cap forecast ; Conservative stock forecast ranks higher 68. Known as Sangamo Biosciences, Inc. ( SGMO ) at Nasdaq.com vote. ) 500 the! Resistance level at $ 13.66 to a day low at $ 14.53 Consumer news, historical charts, analyst for. View our full suite of financial calendars and market data tables, for! $ 18.13, for a total transaction of $ 25.00 Engine, data export tools, research reports in past! The target high Public Anchor top stocks trading ideas '' stock price forecast, news and forecasts real-time financial and! Several recent research reports `` Buy '' rating, but there may be different sangamo stock forecast. Subscribers can Access stock screeners, 4th for your stocks companies, like Sangamo Therapeutics stock. Market trust in this company of dividend growth J.P. Morgan downgrade MarketWatch early stage sangamo stock forecast! On a Big Move in Sangamo Therapeutics and other stocks us improve free!

Unc Charlotte Softball Roster, Michigan State Cross Country Meet 2020, Unc Charlotte Softball Roster, Virtual School Tips For Students, How Much To Rent Château Vaux-le-vicomte, Trendy Restaurants In Raleigh,